The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours.

about

A Protocol for the Preparation of Cryoprecipitate and Cryo-depleted Plasma for Proteomic Studies.Characteristics of thawed pooled cryoprecipitate stored at refrigerated temperature for 24 hours.

P2860

Q45869415-8E4AB9B8-276C-4CFD-AF34-8DB62515BEC0 Q50141409-D09479B9-8A07-430F-A2A6-6ABEC9AC156E

P2860

The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours.

Item

http://www.wikidata.org/entity/Q39136839

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours.

@en

The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours.

@nl

type

Item

label

The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours.

@en

The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours.

@nl

prefLabel

The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours.

@en

The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours.

@nl

P1476

The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours

@en

P2093

Lucy Backholer

http://www.w3.org/2001/XMLSchema#string

Mike Wiltshire

http://www.w3.org/2001/XMLSchema#string

Rebecca Cardigan

http://www.w3.org/2001/XMLSchema#string

Simon J Stanworth

http://www.w3.org/2001/XMLSchema#string

P2860

Calibrated automated thrombin generation measurement in clotting plasma

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.

Factor XIII (FXIII) and angiogenesis.

Mortality from trauma haemorrhage and opportunities for improvement in transfusion practice.

The haematological features and transfusion management of women who required massive transfusion for major obstetric haemorrhage in the UK: a population based study.

Factor XIII--an under diagnosed deficiency--are we using the right assays?

Cryoprecipitate for transfusion: which patients receive it and why? A study of patterns of use across three regions in England.

The effect of cryoprecipitate concentrate in patients with classical haemophilia.

A practical guideline for the haematological management of major haemorrhage.

P304

1356-1361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRF.13571

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Laura Green

Sean Platton

P577

2016-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27019386

http://www.w3.org/2001/XMLSchema#string

The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours.

about

P2860

P2860

The hemostatic properties of thawed pooled cryoprecipitate up to 72 hours.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698